Skip to main content
. 2014 Nov 10;9(11):e110787. doi: 10.1371/journal.pone.0110787

Figure 1. Plasma sCD30 levels and CD30 mRNA expressions in BMMCs from AA patients (n = 42) and healthy individuals (n = 20).

Figure 1

(A) BM plasma sCD30 concentrations in healthy individuals (n = 20), Non-SAA patients (n = 13), SAA patients (n = 11) and VSAA patients (n = 8) were measured by ELSIA. (B) The ratios of BM plasma sCD30 level/PB plasma sCD30 level in SAA and VSAA patients (n = 11) and in healthy individuals (n = 11). (C) Relative expressions of CD30 in BMMNCs were measured by real-time PCR in de novo SAA patients (n = 12) and healthy individuals (n = 11).